한글목차

세계 신경가소성 시장은 2025년에 111억 7,000만 달러, 2032년에는 615억 3,000만 달러에 달하고, 2025-2032년 연평균 27.6%의 성장률을 보일 것으로 예측됩니다.

그림. 2025년 지역별 신경가소성 시장 점유율(%)

신경가소성에는 신경 피드백 시스템, 뇌 자극기, 인지 훈련 프로그램, 뇌 기능을 최적화하고 신경가소성 변화를 촉진하기 위해 고안된 기타 치료법 등 다양한 개입이 포함됩니다.

시장 역학:

신경 질환의 유병률 증가와 비침습적 뇌 자극 기술에 대한 수요 증가는 예측 기간 동안 세계 신경가소성 시장의 성장을 가속할 것으로 예상되는 주요 요인입니다.

그러나 인식 부족, 제한된 연구개발, 높은 비용은 예측 기간 동안 신경가소성 시장의 성장을 저해할 것으로 예측됩니다.

이 조사의 주요 특징

• 세계의 신경가소성 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 신경가소성 시장의 주요 기업 프로파일을 제공합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 신경가소성 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 신경가소성 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차 :

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 발매/승인
• PEST 분석
• PORTER 분석
• 인수합병(M&A) 시나리오

제4장 세계의 신경가소성 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 신경가소성 시장, 제품 유형별, 2020년-2032년

• 소프트웨어 기반 솔루션
• 하드웨어 기반 솔루션

제6장 세계의 신경가소성 시장, 용도별, 2020년-2032년

• 뇌졸중 재활치료
• 외상성 뇌손상(TBI) 재활치료
• 신경퇴행성 질환
• 학습 및 기억 강화
• 정신질환

제7장 세계의 신경가소성 시장, 최종사용자별, 2020년-2032년

• 병원 및 진료소
• 연구기관 및 학술 센터
• 제약 및 바이오테크놀러지 기업
• 기타

제8장 세계의 신경가소성 시장, 지역별, 2020년-2032년

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제9장 경쟁 구도

• NeuroSky Inc
• Posit Science Corporation
• BrainHQ
• Synaptitude Brain Health
• Mindmaze SA
• NeuroVigil Inc.
• Lumosity
• Neuronetics, Inc
• CogniFit
• SharpBrains
• Emotiv Inc
• BrainCo
• Neuroscape
• Neuroplast BV
• Reha Technology AG
• Virtualware Group
• Nexeon Medsystems Inc

제10장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Global Neuroplasticity Market is estimated to be valued at USD 11.17 Bn in 2025 and is expected to reach USD 61.53 Bn by 2032, growing at a compound annual growth rate (CAGR) of 27.6% from 2025 to 2032.

Figure. Neuroplasticity Market Share (%), By Region 2025

Neuroplasticity encompasses various interventions, such as neurofeedback systems, brain stimulation devices, cognitive training programs, and other therapies designed to optimize brain function and promote neuroplastic changes.

Market Dynamics:

The increasing prevalence of neurological disorders and growing demand for non-invasive brain stimulation techniques are major factors expected to drive growth of the global neuroplasticity market during the forecast period.

However, lack of awareness, limited research and development, and high costs are expected to hamper the growth of the neuroplasticity market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global neuroplasticity market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global neuroplasticity market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include NeuroSky Inc., Posit Science Corporation, BrainHQ, Synaptitude Brain Health, Mindmaze SA, NeuroVigil Inc., Lumosity, Neuronetics, Inc., CogniFit, BrainHQ, SharpBrains, Emotiv Inc., BrainCo, Neuroscape, Neuroplast BV, Reha Technology AG, Virtualware Group, Nexeon Medsystems Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global neuroplasticity market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroplasticity market

Detailed Segmentation:

• By Product Type:
  • Software-Based Solutions
  • Hardware-Based Solutions
• By Application:
  • Stroke Rehabilitation
  • Traumatic Brain Injury (TBI) Rehabilitation
  • Neurodegenerative Disorders
  • Learning and Memory Enhancement
  • Mental Health Disorders
• By End User:
  • Hospitals and Clinics
  • Research Institutes and Academic Centers
  • Pharmaceutical and Biotechnology Companies
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • NeuroSky Inc.
  • Posit Science Corporation
  • BrainHQ
  • Synaptitude Brain Health
  • Mindmaze SA
  • NeuroVigil Inc.
  • Lumosity
  • Neuronetics, Inc.
  • CogniFit
  • BrainHQ
  • SharpBrains
  • Emotiv Inc.
  • BrainCo
  • Neuroscape
  • Neuroplast BV
  • Reha Technology AG
  • Virtualware Group
  • Nexeon Medsystems Inc.

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Global Neuroplasticity, By Product Type
  • Market Global Neuroplasticity, By Application
  • Market Global Neuroplasticity, By End User
  • Market Global Neuroplasticity, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of neurological disorders
  • Increasing research and development activities
  • Technological advancements
  • Growing demand for non-invasive and personalized treatments
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Neuroplasticity Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Neuroplasticity Market, By Product Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Software-Based Solutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Hardware-Based Solutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Neuroplasticity Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Stroke Rehabilitation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Traumatic Brain Injury (TBI) Rehabilitation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Neurodegenerative Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Learning and Memory Enhancement
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Mental Health Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Neuroplasticity Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Research Institutes and Academic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Neuroplasticity Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  • U.S.
  • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• NeuroSky Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Posit Science Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BrainHQ
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Synaptitude Brain Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mindmaze SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• NeuroVigil Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lumosity
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Neuronetics, Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CogniFit
• SharpBrains
• Emotiv Inc
• BrainCo
• Neuroscape
• Neuroplast BV
• Reha Technology AG
• Virtualware Group
• Nexeon Medsystems Inc
• Analyst Views

10. Section

• Research Methodology
• About us